[HTML][HTML] Mutation in WDR4 impairs tRNA m7G46 methylation and causes a distinct form of microcephalic primordial dwarfism

R Shaheen, GMH Abdel-Salam, MP Guy, R Alomar… - Genome biology, 2015 - Springer
R Shaheen, GMH Abdel-Salam, MP Guy, R Alomar, MS Abdel-Hamid, HH Afifi, SI Ismail…
Genome biology, 2015Springer
Background Primordial dwarfism is a state of extreme prenatal and postnatal growth
deficiency, and is characterized by marked clinical and genetic heterogeneity. Results Two
presumably unrelated consanguineous families presented with an apparently novel form of
primordial dwarfism in which severe growth deficiency is accompanied by distinct facial
dysmorphism, brain malformation (microcephaly, agenesis of corpus callosum, and
simplified gyration), and severe encephalopathy with seizures. Combined …
Background
Primordial dwarfism is a state of extreme prenatal and postnatal growth deficiency, and is characterized by marked clinical and genetic heterogeneity.
Results
Two presumably unrelated consanguineous families presented with an apparently novel form of primordial dwarfism in which severe growth deficiency is accompanied by distinct facial dysmorphism, brain malformation (microcephaly, agenesis of corpus callosum, and simplified gyration), and severe encephalopathy with seizures. Combined autozygome/exome analysis revealed a novel missense mutation in WDR4 as the likely causal variant. WDR4 is the human ortholog of the yeast Trm82, an essential component of the Trm8/Trm82 holoenzyme that effects a highly conserved and specific (m7G46) methylation of tRNA. The human mutation and the corresponding yeast mutation result in a significant reduction of m7G46 methylation of specific tRNA species, which provides a potential mechanism for primordial dwarfism associated with this lesion, since reduced m7G46 modification causes a growth deficiency phenotype in yeast.
Conclusion
Our study expands the number of biological pathways underlying primordial dwarfism and adds to a growing list of human diseases linked to abnormal tRNA modification.
Springer